Prof. Dr. SEVGİ TAKKA

Yayın Ağı

Makaleler 40

1. Development of immediate release tablet formulations of lornoxicam with hot melt extrusion-based three-dimensional printing technology

Yilmaz A., Mutlu-Agardan N. B., TAKKA S.

Drug Development and Industrial Pharmacy , cilt.51, sa.1, ss.64-76, 2025 (SCI-Expanded)

2. The antimicrobial effect of R-limonene and its nano emulsion on Enterococcus faecalis - In vitro study

Seker I. D., ALAÇAM T., AKCA G., Yilmaz A., TAKKA S.

EUROPEAN ORAL RESEARCH , cilt.59, sa.1, ss.33-39, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

3. AN OVERVIEW OF 3D PRINTING TECHNOLOGIES FOCUSING MULTIDRUG-LOADED 3D PRINTED DOSAGE FORMS

Yılmaz A., Mutlu Ağardan N. B., Takka S.

ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.49, sa.1, ss.228-240, 2025 (Scopus)

4. Ocular Drug Delivery Routes: Diseases Overview and Advanced Administration Methods

TUĞCU DEMİRÖZ F. N., TAKKA S., Yetgin C.

FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.49, ss.627-646, 2024 (Scopus)

5. Cell culture and pharmacokinetic evaluation of a solid dosage formulation containing a water-insoluble orphan drug manufactured by FDM-3DP technology

Saydam M., TİMUR S. S., Vural M., TAKKA S.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.628, 2022 (SCI-Expanded)

6. Development and characterization of polymeric nanoparticles containing ondansetron hydrochloride as a hydrophilic drug

ÖZDAL Z. D., Gültekin Y., VURAL İ., TAKKA S.

Journal of Drug Delivery Science and Technology , cilt.74, 2022 (SCI-Expanded)

7. The antimicrobial effect of R-limonene and its nanoemulsion on Enterococcus faecalis-In vitro study

ŞEKER İ. D., ALAÇAM T., AKCA G., YILMAZ A., TAKKA S.

Research Square , 2022 (Hakemli Dergi)

8. Formulation Development Studies of Three-Dimensional Printable Filaments Containing Eudragit S100 Polymer with High-Glass Transition Temperature

Takka S., Duran C., Sarısaltık D.

Formulation Development Studies of Three-Dimensional Printable Filaments Containing Eudragit S100 Polymer with High-Glass Transition Temperature , cilt.4, sa.1179331, ss.144-151, 2022 (Hakemli Dergi)

9. Development and characterization of camphor-loaded ozonated olive oil nanoemulsions

Yalçın T. E., Takka S.

Journal of Research in Pharmacy , cilt.24, sa.6, ss.935-942, 2020 (ESCI)

10. Improving the dissolution of a water-insoluble orphan drug through a fused deposition modelling 3-Dimensional printing technology approach

Saydam M., TAKKA S.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.152, 2020 (SCI-Expanded)

11. Tümöral Ekstraselüler Matriks Bileşenlerine Kemoterapötik İlaç Hedefleme

Yılmaz A., Takka S.

FABAD J. Pharm. Sci , cilt.45, sa.2, ss.175-186, 2020 (Hakemli Dergi)

12. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.580, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Bioavailability File: Rufinamide

Saydam M., TAKKA S.

FABAD , cilt.44, sa.3, ss.231-242, 2019 (Hakemli Dergi)

14. Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools

Saydam M., TAKKA S.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.44, sa.12, ss.1905-1917, 2018 (SCI-Expanded)

15. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.548, sa.1, ss.255-262, 2018 (SCI-Expanded)

16. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity

YALÇIN T. E., İLBASMIŞ TAMER S., Ibisoglu B., ÖZDEMİR A., ARK M., TAKKA S.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.23, sa.1, ss.76-86, 2018 (SCI-Expanded)

17. Effect of Organic Solvents on Gemcitabine Loaded PLGA Nanoparticles

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

FABAD Journal of Pharmaceutical Sciences , cilt.42, ss.15-19, 2017 (Scopus)

18. Bile salt-reinforced alginate-chitosan beads

TAKKA S., Cali A. G.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.17, sa.1, ss.23-29, 2012 (SCI-Expanded)

19. Evaluation of Chitosan/Alginate Beads Using Experimental Design: Formulation and In Vitro Characterization

TAKKA S., Gurel A.

AAPS PHARMSCITECH , cilt.11, sa.1, ss.460-466, 2010 (SCI-Expanded)

20. FLOATING MATRIX TABLETS BASED ON LOW DENSITY FOAM POWDER

TAKKA S., Kuzu D.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.78-79, 2009 (SCI-Expanded)

21. Evaluation of alginate based mesalazine tablets for intestinal drug delivery

Tugcu-Demiroez F., Acartuerk F., Takka S., Konus-Boyunaga Ö. L.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , cilt.67, sa.2, ss.491-497, 2007 (SCI-Expanded)

22. Bioavailability file Valsartan

Saydam M., TAKKA S.

Fabad Journal of Pharmaceutical Sciences , cilt.32, sa.4, ss.185-196, 2007 (Scopus)

23. Investigation of colon-specific dosage forms of ondansetron prepared with natural polymers

TUĞCU DEMİRÖZ F. N., Acarturk F., Takka S.

PHARMAZIE , cilt.61, sa.11, ss.916-919, 2006 (SCI-Expanded)

24. Development and in vivo evaluation of extended release dextromethorphan tablets Part 1

Bharaj S., Takka S., Kelm G., Sakr A.

PHARMAZEUTISCHE INDUSTRIE , cilt.68, sa.1, ss.116-119, 2006 (SCI-Expanded)

25. Development and in vivo evaluation of extended release dextromethorphan tablets Part 2

Bharaj S., Takka S., Kelm G., Sakr A.

PHARMAZEUTISCHE INDUSTRIE , cilt.68, sa.2, ss.247-249, 2006 (SCI-Expanded)

26. In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery

TUĞCU DEMİRÖZ F. N., Acarturk F., Takka S., Konus-Boyunaga Ö. L.

JOURNAL OF DRUG TARGETING , cilt.12, sa.2, ss.105-112, 2004 (SCI-Expanded)

27. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide

Takka S., Bharaj S., Sakr A.

PHARMAZIE , cilt.58, sa.12, ss.886-890, 2003 (SCI-Expanded)

28. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets

Takka S., Sakr A., Goldberg A.

JOURNAL OF CONTROLLED RELEASE , cilt.88, sa.1, ss.147-157, 2003 (SCI-Expanded)

29. Propranolol hydrochloride anionic polymer binding interaction

TAKKA S.

Farmaco , cilt.58, sa.10, ss.1051-1056, 2003 (Hakemli Dergi)

30. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets

Takka S., Rajbhandari S., Sakr A.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , cilt.52, sa.1, ss.75-82, 2001 (SCI-Expanded)

31. Pectin-hydroxypropylmethylcellulose drug delivery system for colon targeting - Design and in vitro evaluation

Turkoglu M., Takka S., Baran H., Sakr A.

PHARMAZEUTISCHE INDUSTRIE , cilt.61, sa.7, ss.662-665, 1999 (SCI-Expanded)

32. Calcium alginate microparticles for oral administration: II effect of formulation factors on drug release and drug entrapment efficiency

Acarturk F., Takka S.

JOURNAL OF MICROENCAPSULATION , cilt.16, sa.3, ss.291-301, 1999 (SCI-Expanded)

33. Calcium alginate microparticles for oral administration: I: effect of sodium alginate type on drug release and drug entrapment efficiency

Takka S., Acarturk F.

JOURNAL OF MICROENCAPSULATION , cilt.16, sa.3, ss.275-290, 1999 (SCI-Expanded)

34. Calcium alginate microparticles for oral administration: III. The effect of crosslink agents and various additive polymers on drug release and drug entrapment efficiency

Takka S., Acarturk F.

PHARMAZIE , cilt.54, sa.2, ss.137-139, 1999 (SCI-Expanded)

35. Formulation and investigation of nicardipine HCl-alginate gel beads with factorial design-based studies

Takka S., Ocak O., Acarturk F.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.6, sa.3, ss.241-246, 1998 (SCI-Expanded)

36. The use alginic acid and salts in pharmaceutical technology

TAKKA S., ACARTÜRK F.

FABAD Journal of Pharmaceutical Sciences , 1998 (Scopus)

37. Influence of the preparation method on the dissolution characteristics of ibuprofen with low molecular gelatin

Acartürk F., Takka S., Ağabeyoğlu İ., Özkan Y., Yalım G., Şimşek R.

Pharmazie , cilt.48, ss.761-763, 1993 (SCI-Expanded)

38. Felodipin

Takka S., Acartürk F.

FABAD Farm. Bil. Der. , cilt.17, ss.307-320, 1992 (Hakemli Dergi)

39. Formulation and in vitro-in vivo evaluations on sustained release acetylsalicylic acid tablets

ÇAPAN Y., ŞENEL S., ÇALIŞ S., Takka S., Hincal A.

Pharmazeutische Industrie , cilt.51, sa.4, ss.443-448, 1989 (SCI-Expanded)

40. Papaverin Hidroklorür

Takka S., Şumnu M., Hıncal A. A.

FABAD Farm. Bil. Der , cilt.13, ss.480-488, 1988 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 37

1. Effect of Plasticizers on Soluplus® filaments Produced with Hot Melt Extrusion Technique

Yılmaz A., Mutlu Ağardan N. B., Takka S.

5th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2022, Ankara, Türkiye, 23 - 25 Kasım 2022, ss.317, (Özet Bildiri)

2. TRANSFERSOMES FOR TOPICAL OCULAR ADMINISTRATION: DEVELOPMENT AND IN VITRO CHARACTERIZATION

Yetgin C., Tuğcu Demiröz F. N., Takka S.

5TH INTERNATIONAL EURASIAN CONFERENCE ON BIOLOGICAL AND CHEMICAL SCIENCES, Ankara, Türkiye, 23 Kasım 2022, (Özet Bildiri)

3. PREPARATION AND IN VITRO CHARACTERIZATION OF ONDANSETRON HYDROCHLORIDE LOADED LIPOSOME FORMULATIONS

Özdal Z. D., Takka S.

9th BBBB International Conference on Pharmaceutical Sciences, Ljubljana, Slovenya, 15 - 17 Eylül 2022, ss.206-207, (Tam Metin Bildiri)

4. DEVELOPMENT AND EVALUATION OF GANCICLOVIR LOADED NIOSOMES FOR THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS

YETGİN C., ÇOBAN Ö., TUĞCU DEMİRÖZ F. N., TAKKA S.

FİGON DMD & EUFEPS Annual Meeting 2022, Leiden, Hollanda, 01 Haziran 2022, (Özet Bildiri)

5. EVALUATION OF THE IN VITRO CYTOTOXICITY AND CHARACTERIZATION OF ONDANSETRON HYDROCHLORIDE LOADED NANOPARTICLES

ÖZDAL Z. D., GÜLTEKİN Y., VURAL İ., TAKKA S.

20th International Pharmaceutical Technology Symposium - IPTS 2022, 21 - 23 Şubat 2022, (Tam Metin Bildiri)

6. EVALUATION OF THE IN VITRO CYTOTOXICITY AND CHARACTERIZATION OF ONDANSETRON HYDROCHLORIDE LOADED NANOPARTICLES

Özdal Z. D., Takka S., Vural İ.

International Pharmaceutical Technology Symposium, Ankara, Türkiye, 21 - 23 Şubat 2022, ss.78-80, (Tam Metin Bildiri)

7. PREPARATİON AND EVALUATİON ONDANSETRON HCl LOADED POLYMERİC NANOPARTİCLES

Özdal Z. D., Takka S.

3. International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 Eylül - 10 Ekim 2021, ss.100, (Özet Bildiri)

8. EFFECT OF POLYMER ON ONDANSETRON HCl LOADED POLYMERIC NANOPARTICLES

Özdal Z. D., Takka S.

13. International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 22 - 25 Haziran 2021, ss.177-178, (Özet Bildiri)

9. THE ANTIMICROBIAL EFFECT OF R-LIMONENE NANOEMULSION ON ENTEROCOCCUS FAECALIS

Yılmaz A., Şeker İ. D., Akca G., Takka S., Alaçam T.

3rd International Gazi Pharma Symposium Series (GPSS), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.142, (Özet Bildiri)

10. EVALUATION OF THE EFFECT OF INFILL DENSITY AND TABLET GEOMETRY ON DISINTEGRATION OF 3D PRINTED TABLETS

Duran C., Takka S.

3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 09 Eylül 2021, ss.143, (Özet Bildiri)

11. DEVELOPMENT OF A PRINTABLE COATING FILAMENT FOR 3D COLON TARGETING TABLETS

Duran C., Takka S.

ISOPS 13, Ankara, Türkiye, 21 - 23 Haziran 2021, ss.18-20, (Tam Metin Bildiri)

12. DEVELOPMENT AND EVALUATION OF METFORMIN HYDROCHLORIDE LOADED ALGINAT-PLGA NANOPARTICLES

Yılmaz A., Takka S.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Türkiye, 14 - 16 Ekim 2019, ss.1-2, (Özet Bildiri)

13. IMPROVING THE SOLUBILITY AND DISSOLUTION OF A WATER INSOLUBLE ORPHAN DRUG WITH 3 DIMENSIONAL PRINTING (3DP)

TAKKA S., Saydam M.

8th BBBB International Conferance on Pharmaceutical Sciences, 14 - 16 Ekim 2019, ss.67-69, (Tam Metin Bildiri)

14. Nanoformulations For Dermally Application

OKTAY A. N., İLBASMIŞ TAMER S., TAKKA S.

17th Edition of International Conference and Exhibition on Pharmaceutics Novel Drug Delivery Systems, 4 - 06 Ekim 2018, (Özet Bildiri)

15. Development of Solid Dosage Forms of an Orphan Drug with 3 Dimensional Printing (3DP) by Using Quality by Design (QbD) Tools

Saydam M., TAKKA S.

International Pharmaceutical Technology Symposium (IPTS), Ankara, Türkiye, 17 - 19 Eylül 2018, ss.138-139, (Tam Metin Bildiri)

16. Gemcitabine Hydrochloride Loaded Lipid Polymer Hybrid Nanoparticles (LPHNs): In Vivo Evaluation For Breast Cancer Therapy

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

19th International Pharmaceutical Technology Symposium (IPTS), Antalya, Türkiye, 17 - 19 Eylül 2018, ss.154-155, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

17. Formulation Optimization Of Lipid Polymer Hybrid Nanoparticles (LPHNS) Using Central Composite Design

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

International Pharmaceutical Technology Symposium (IPTS), Antalya, Türkiye, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

18. Stability of Gemcitabine Hydrochloride Loaded LPHNs in Phosphate Buffer Solution and Fetal Bovine Serum

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Özet Bildiri)

19. Stability of Gemcitabine Hydrochloride Loaded LPHNs on Different Storage Conditions

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Özet Bildiri)

20. Accelerated and Long-Term Stability Studies For Gemcitabine Hydrochloride Loaded Liposomes and Nanoparticles

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

2nd International Gazi Pharma Symposium Series, GPSS, 11 - 13 Ekim 2017, (Özet Bildiri)

21. Stability Studies of Gemcitabine Hydrochloride Loaded Liposomes and Nanoparticles in Various Media

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

2nd International Gazi Pharma Symposium Series, GPSS, 11 - 13 Ekim 2017, (Özet Bildiri)

22. Preparation and Characterization of Gemcitabine HCI Loaded Lipid Polymer Hybrid Nanoparticles

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

14th European Symposium on Controlled Drug Deliery, 13 - 15 Nisan 2016, ss.179, (Tam Metin Bildiri)

23. Preparation and Characterization of Gemcitabine HCl Loaded Lipid Polymer Hybrid Nanoparticles

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

14th European Symposium on Controlled Drug Delivery, Egmond aan Zee, Hollanda, 13 - 15 Nisan 2016, (Özet Bildiri)

24. The Effect of Type of Organic Phase Solvents on the Characteristics of Gemcitabine HCl Loaded Poly lactic Co Glycolic Acid Nanoparticles

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

GPPS Gazi Pharma Smposium Series, Antalya, Türkiye, 12 - 14 Kasım 2015

25. APPLICATION OF QUALITY BY DESIGN QbD TOOLS AND BIOPHARMACEUTICAL CLASSIFICATION SYSTEM BCS IN DEVELOPING PH INDEPENDENT CONTROLLED RELEASE MATRIX TABLET

Saydam M., TAKKA S.

GPSS 2015, 12 - 14 Kasım 2015

26. Development and Characterization of Gemcitabine Hydrochloride Loaded Liposomes

YALÇIN T. E., İLBASMIŞ TAMER S., TAKKA S.

AAPS Annual Meeting, World Congress in Association with the AAPS Annual Meeting and Exposition, Orlando/Florida, Amerika Birleşik Devletleri, 23 - 29 Ekim 2015, (Özet Bildiri)